Erratum: Acknowledgments correction

ERRATUM: Acknowledgments Correction. Bioinformatics Interpretation of Exome Sequencing: Blood Cancer

ERRATUM: Acknowledgments Correction. Cell-Free miR-27a, a Potential Diagnostic and Prognostic Biomarker for Gastric Cancer

[This corrects the article on p. 70 in vol. 13, PMID: 26523130.].

Erratum, Vol. 11, January 30 Release

In the article, “Public Support for Smoke-Free Air Strategies Among Smokers and Nonsmokers, New York City, 2010– 2012,” the authors inadvertently listed the wrong grant number in the Acknowledgments section. The correct grant number is Cooperative Agreement number 1U58DP002419–01 from the Centers for Disease Control and Prevention – Communities Putting Prevention to Work. The correction was mad...

Erratum, Vol. 9, September 27 Release

In the article “Factors Associated With Poor Glycemic Control or Wide Glycemic Variability Among Diabetes Patients in Hawaii, 2006-2009,” one of the funding sources for the study was not mentioned in the Acknowledgments section. The additional funding source is ARRA grant no. 3P20MD000173–09S1 from the National Institute on Minority Health and Health Disparities. The correction was made to our ...

Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis

The author of the above-mentioned paper would like to make the following correction to the first paragraph of the Acknowledgments section on page 16. ‘‘The author received editorial support in the preparation of this report from Kristin Carlin and Jennifer Schwinn, Peloton Advantage, LLC, Parsippany, NJ, USA, funded by Celgene Corporation, Summit, NJ, USA. The author, however, directed and is f...